Toll Free: 1-888-928-9744

Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2016

Published: Jun 1, 2016 | Pages: 34 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2016" provides an overview of Peripherally Inserted Central Catheter (PICC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripherally Inserted Central Catheter (PICC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripherally Inserted Central Catheter (PICC) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripherally Inserted Central Catheter (PICC) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons To Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripherally Inserted Central Catheter (PICC) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 3 1.2 List of Figures 3 2 Introduction 4 2.1 Peripherally Inserted Central Catheter (PICC) Overview 4 3 Products under Development 5 3.1 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 5 3.2 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory 6 3.3 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path 7 3.4 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date 8 4 Peripherally Inserted Central Catheter (PICC) - Pipeline Products under Development by Companies 9 4.1 Peripherally Inserted Central Catheter (PICC) Companies - Pipeline Products by Stage of Development 9 4.2 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 10 5 Peripherally Inserted Central Catheter (PICC) Companies and Product Overview 11 5.1 AngioDynamics, Inc. Company Overview 11 5.1.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 11 5.2 C. R. Bard, Inc. Company Overview 14 5.2.1 C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14 5.3 NexGen Medical Systems, Inc. Company Overview 20 5.3.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20 5.4 University of Texas Health Science Center at Houston Company Overview 21 5.4.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 21 6 Peripherally Inserted Central Catheter (PICC)- Recent Developments 23 6.1 May 11, 2016: Teleflex Prices Public Offering of 4.875% Notes Due 2026 for USD400 Million 23 6.2 May 10, 2016: ICU Medical Announces First Quarter 2016 Results 23 6.3 May 03, 2016: Cook Medical Issues Global, Voluntary Recall of Catheters with Beacon Tip Technology 24 6.4 Feb 03, 2016: ICU Medical Announces Fourth Quarter and Fiscal Year 2015 Results 25 6.5 Jan 11, 2016: Teleflex Highlights a Comparison of Eluting vs Non-Eluting Technologies on Peripherally Inserted Central Catheters (PICCs) in Preventing Thrombus Accumulation 26 6.6 Nov 05, 2015: ICU Medical Announces Third Quarter 2015 Results 26 6.7 Oct 28, 2015: Access Scientific's POWERWAND Midline IV Catheter Sets New Industry Standard for Power Injectabilty 27 6.8 Sep 30, 2015: Galt Medical and Health Line Launch Nexus CT Midline Catheter with MST Insertion Kit 27 6.9 Sep 30, 2015: Tangent Medical Technologies Raises USD1 Million in Financing 28 6.10 Sep 23, 2015: Teleflex to Showcase Arrow Endurance Extended Dwell Peripheral Catheter System at AVA 2015 Meeting in Dallas 28 6.11 Sep 23, 2015: B. Braun to Sponsor Platinum Showcase and Present at AVA 29 6.12 Aug 10, 2015: ICU Medical Announces Second Quarter 2015 Results 29 7 Appendix 31 7.1 Methodology 31 7.2 About GlobalData 33 7.3 Contact Us 34 7.4 Disclaimer 34
List of Tables
Table 1: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 5 Table 2: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory 6 Table 3: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path 7 Table 4: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date 8 Table 5: Peripherally Inserted Central Catheter (PICC) Companies - Pipeline Products by Stage of Development 9 Table 6: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 10 Table 7: AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 11 Table 8: BioFlo PICC Line Extension - Product Status 12 Table 9: BioFlo PICC Line Extension - Product Description 12 Table 10: Next Generation BioFlo PICC - Product Status 13 Table 11: Next Generation BioFlo PICC - Product Description 13 Table 12: C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14 Table 13: 3CG Port Placement System - Product Status 15 Table 14: 3CG Port Placement System - Product Description 15 Table 15: Antimicrobial PICC - Product Status 16 Table 16: Antimicrobial PICC - Product Description 16 Table 17: COVERT PowerPICC - Product Status 17 Table 18: COVERT PowerPICC - Product Description 17 Table 19: Internal Jugular Placement Catheter - Product Status 18 Table 20: Internal Jugular Placement Catheter - Product Description 18 Table 21: Thromboresistant PICC - New Version - Product Status 19 Table 22: Thromboresistant PICC - New Version - Product Description 19 Table 23: NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20 Table 24: Channel Catheter - Product Status 20 Table 25: Channel Catheter - Product Description 20 Table 26: University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 21 Table 27: Automated Catheter Insertion System - Product Status 22 Table 28: Automated Catheter Insertion System - Product Description 22 Table 29: Glossary 32


List of Figures
Figure 1: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development 5 Figure 2: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory 6 Figure 3: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path 7 Figure 4: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date 8

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...

Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance driv

Read More...

Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous indust

Read More...

Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from main

Read More...

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify